FDA approves Pfizer COVID-19 vaccine
A Food and Drug Administration advisory panel approved of broad distribution of the Pfizer COVID-19 vaccine, the Wall Street Journal reports.
Moderna intends to submit for an Emergency Use Authorization (EUA) with the U.S. Food and Drug Administration (FDA) in the coming weeks. Moderna also plans to apply for authorization from global regulatory agencies.
During a speech update on Operation Warp Speed from the Rose Garden, President Donald Trump announced that the White House won't be delivering the COVID-19 vaccine to the state of New York unless authorized because Gov. Andrew Cuomo doesn't trust the current administration.